Break down of GENOMMA LAB manpower and management performance that can provide insight into the company performance. Note, an employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with GENOMMA LAB INTERNAC future performance. GENOMMA LAB employes about 907 people. The company is managed by 24 executives with total tenure of roughly 59 years, averanging almost 2.0 years of service per executive having 1.0 employee per reported executive. See also Stocks Correlation
| ||Rodrigo Aspra Chairman|
Chairman of the Board, Independent Director
GENOMMA LAB Management Effectiveness
The company has return on total asset (ROA)
of 8.4 %
which means that it generated profit of $8.4 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 11.86 %
meaning that it generated $11.86 on every $100 dollars invested by stockholders.
GENOMMA LAB Workforce Comparison
GENOMMA LAB INTERNACIONAL SAB is currently regarded as number one stock in number of employees category among related companies. The total workforce
of Drug Manufacturers - Specialty & Generic
industry is now estimated at about 103,990. GENOMMA LAB maintains roughly 907 in number of employees contributing less than 1% to equities under Drug Manufacturers - Specialty & Generic industry.
GENOMMA LAB Profit Margins
The company has Profit Margin (PM) of 7.54 %
which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 19.8 %
which suggests for every 100 dollars of sales it generated a net operating income of 0.2.
GENOMMA LAB Stakeholders